Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life assessment

BACKGROUND: Patients with refractory or relapsed acute myeloid leukemia (AML) have poor survival, necessitating the exploration of optimized therapeutic strategy. Here, we aimed to investigate clinical outcomes and health‐related quality of life (HR‐QoL) after total therapy, which included allogenei...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Chen‐hua, Wang, Yu, Sun, Yu‐qian, Cheng, Yi‐fei, Mo, Xiao‐dong, Wang, Feng‐rong, Chen, Yu‐hong, Zhang, Yuan‐yuan, Han, Ting‐ting, Chen, Huan, Xu, Lan‐ping, Zhang, Xiao‐hui, Liu, Kai‐yan, Huang, Xiao‐jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759766/
https://www.ncbi.nlm.nih.gov/pubmed/36274263
http://dx.doi.org/10.1002/cac2.12376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759766/
https://www.ncbi.nlm.nih.gov/pubmed/36274263
http://dx.doi.org/10.1002/cac2.12376

Ejemplares similares